ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 50 filers reported holding ALBIREO PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,390,000 | -15.8% | 105,154 | -15.9% | 0.14% | -15.9% |
| Q1 2019 | $4,026,000 | +31.3% | 125,000 | 0.0% | 0.16% | +25.2% |
| Q4 2018 | $3,066,000 | -25.6% | 125,000 | 0.0% | 0.13% | -12.1% |
| Q3 2018 | $4,120,000 | -7.2% | 125,000 | 0.0% | 0.15% | -11.3% |
| Q2 2018 | $4,438,000 | +9.0% | 125,000 | 0.0% | 0.17% | +6.3% |
| Q1 2018 | $4,071,000 | – | 125,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 198,800 | $5,266,000 | 2.26% |
| Perceptive Advisors | 1,960,139 | $51,924,000 | 0.84% |
| Chicago Capital, LLC | 502,212 | $13,304,000 | 0.77% |
| Birchview Capital, LP | 48,000 | $1,272,000 | 0.77% |
| Artal Group S.A. | 500,360 | $13,255,000 | 0.37% |
| HEARTLAND ADVISORS INC | 150,000 | $3,974,000 | 0.35% |
| Eversept Partners, LP | 78,029 | $2,066,988 | 0.28% |
| ArrowMark Colorado Holdings LLC | 956,990 | $25,351,000 | 0.26% |
| PA Capital LLC | 12,987 | $344,000 | 0.25% |
| Ikarian Capital, LLC | 100,500 | $2,662,000 | 0.21% |